Osteoarthritis: Pharmacological and Nonpharmacological Treatment Options is organized by ContinuingEducation.com - OnCourse Learning Corporation and will be held during Jan 16, 2013 - Oct 06, 2019.
The target audience for this medical event is multiple professions, including pharmacists, pharmacy techs, and fitness professionals. This CME Conference has been approved for a maximum of 1.00 Contact Hours.
Osteoarthritis is the most common joint disorder in the United States and affects nearly 20 million people. The disorder primarily affects the large weight-bearing joints, such as the hip, knee, shoulder, cervical spine, ankle, and lumbar spine. The aim of pharmacotherapy for the treatment of OA is to relieve symptoms, reduce morbidity, prevent long-term complications, and improve quality of life. While drug therapy is important for controlling pain, nonpharmacological treatments are first-line recommendations for most patients with OA.
Conference Objectives are :
The goal of this osteoarthritis continuing education program is to provide pharmacists, pharmacy techs, fitness professionals, and other healthcare professionals with adequate information about the causes and presentation of OA, the types of pharmacological and nonpharmacological treatments available, and the role of surgery in its management. After studying the information presented here, you will be able to:
• Review the use of different classes of medications used to treat OA including nonsteroidal anti-inflammatory drugs, steroids, antidepressants, and sodium hyaluronate
• Describe the role of nonpharmacological therapies in the treatment of OA
• Discuss the role of surgical procedures in the treatment of OA
Additional details will be posted as soon as they are available.
Orthopedics, Rheumatology, Clinical Pharmacology